Novo Nordisk notches big GLP-1 sales amid rebounding supplies, but cautions on future ' periodic constraints '

With No­vo Nordisk’s obe­si­ty treat­ment We­govy ful­ly back in stock in De­cem­ber, sales are be­gin­ning to soar, the Dan­ish phar­ma re­port­ed dur­ing its an­nu­al earn­ings call on Wednes­day. To­tal scripts of the glucagon-like pep­tide 1 (GLP-1) We­govy topped 37,000 week­ly in…#danish #wegovy #saxendaaccounted #dkk107 #larsfruergaard #karstenmunkknudsen #glp1 #nordiskreported #dkk177 #victoza

Source: Reuters: Health - February 2, 2023 Category: Consumer Health News Source Type: news